Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), including administration of booster doses, continues to be the most effective method …

Objectives To identify risk factors for progression to severe COVID-19 and estimate the odds
of severe COVID-19 associated with vaccination among patients with systemic lupus …

The present study evaluated the presentations and outcomes of coronavirus disease 2019
(COVID-19) among patients undergoing maintenance hemodialysis (MHD) and the impact …

Methods: Altogether, 67 MHD patients were enroled in the study from two dedicated tertiary-
level hospitals for COVID-19 after the prospective cross-sectional execution of selection …

The aim of this study was to evaluate the risk of COVID-19 in end-stage renal disease
(ESRD) patients, the cost burden of the COVID-19 pandemic on the management of ESRD …

Patients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19.
Characterizing long-term vaccine immune responses in these patients will help optimize …

Background In-center hemodialysis entails repeated interactions between patients and clinic
staff, potentially facilitating the spread of COVID-19. We examined if in-center hemodialysis …

Patients undergoing hemodialysis (HD) are particularly vulnerable to coronavirus disease
2019 (COVID-19) and are at increased risk of developing severe infection. However, given …

Patients with end-stage kidney disease on hemodialysis (ESKD-HD) have a high risk of
contracting severe COVID-19. Vaccination can help reduce disease severity, but the …

Background: The global coronavirus disease 2019 (COVID-19) pandemic has placed
patients with end-stage kidney disease (ESKD) at heightened risk owing to their vulnerability …